For the relationships between LAT1 expression and tumor immunity-related biomarkers, high LAT1 expression was significantly associated with high TILs (p < 0.0001) and PD-L1 positivity (p = 0.00024) (Table 1). Here, SLC7A5 is linked to neoplasm.